Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: Implications for tumor biology and therapy

Congyi Lu, Jason U. Tilan, Lindsay Everhart, Magdalena Czarnecka, Steven J. Soldin, Damodara R. Mendu, Dima Jeha, Jailan Hanafy, Christina K. Lee, Junfeng Sun, Ewa Izycka-Swieszewska, Jeffrey A. Toretsky, Joanna Kitlinska

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY 3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.

Original languageEnglish (US)
Pages (from-to)27494-27505
Number of pages12
JournalJournal of Biological Chemistry
Volume286
Issue number31
DOIs
StatePublished - Aug 5 2011
Externally publishedYes

Fingerprint

Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Ewing's Sarcoma
Neuropeptide Y
Tumors
Cell death
Neoplasms
Cell Death
Therapeutics
Apoptosis Inducing Factor
Membranes
Pediatrics
Poly(ADP-ribose) Polymerases
Fibroblasts
Cell Survival

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lu, C., Tilan, J. U., Everhart, L., Czarnecka, M., Soldin, S. J., Mendu, D. R., ... Kitlinska, J. (2011). Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: Implications for tumor biology and therapy. Journal of Biological Chemistry, 286(31), 27494-27505. https://doi.org/10.1074/jbc.M111.224089

Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors : Implications for tumor biology and therapy. / Lu, Congyi; Tilan, Jason U.; Everhart, Lindsay; Czarnecka, Magdalena; Soldin, Steven J.; Mendu, Damodara R.; Jeha, Dima; Hanafy, Jailan; Lee, Christina K.; Sun, Junfeng; Izycka-Swieszewska, Ewa; Toretsky, Jeffrey A.; Kitlinska, Joanna.

In: Journal of Biological Chemistry, Vol. 286, No. 31, 05.08.2011, p. 27494-27505.

Research output: Contribution to journalArticle

Lu, C, Tilan, JU, Everhart, L, Czarnecka, M, Soldin, SJ, Mendu, DR, Jeha, D, Hanafy, J, Lee, CK, Sun, J, Izycka-Swieszewska, E, Toretsky, JA & Kitlinska, J 2011, 'Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: Implications for tumor biology and therapy', Journal of Biological Chemistry, vol. 286, no. 31, pp. 27494-27505. https://doi.org/10.1074/jbc.M111.224089
Lu, Congyi ; Tilan, Jason U. ; Everhart, Lindsay ; Czarnecka, Magdalena ; Soldin, Steven J. ; Mendu, Damodara R. ; Jeha, Dima ; Hanafy, Jailan ; Lee, Christina K. ; Sun, Junfeng ; Izycka-Swieszewska, Ewa ; Toretsky, Jeffrey A. ; Kitlinska, Joanna. / Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors : Implications for tumor biology and therapy. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 31. pp. 27494-27505.
@article{d3eb5406fd2542328daba588fd4ed748,
title = "Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: Implications for tumor biology and therapy",
abstract = "Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY 3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.",
author = "Congyi Lu and Tilan, {Jason U.} and Lindsay Everhart and Magdalena Czarnecka and Soldin, {Steven J.} and Mendu, {Damodara R.} and Dima Jeha and Jailan Hanafy and Lee, {Christina K.} and Junfeng Sun and Ewa Izycka-Swieszewska and Toretsky, {Jeffrey A.} and Joanna Kitlinska",
year = "2011",
month = "8",
day = "5",
doi = "10.1074/jbc.M111.224089",
language = "English (US)",
volume = "286",
pages = "27494--27505",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors

T2 - Implications for tumor biology and therapy

AU - Lu, Congyi

AU - Tilan, Jason U.

AU - Everhart, Lindsay

AU - Czarnecka, Magdalena

AU - Soldin, Steven J.

AU - Mendu, Damodara R.

AU - Jeha, Dima

AU - Hanafy, Jailan

AU - Lee, Christina K.

AU - Sun, Junfeng

AU - Izycka-Swieszewska, Ewa

AU - Toretsky, Jeffrey A.

AU - Kitlinska, Joanna

PY - 2011/8/5

Y1 - 2011/8/5

N2 - Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY 3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.

AB - Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY 3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.

UR - http://www.scopus.com/inward/record.url?scp=79960982566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960982566&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.224089

DO - 10.1074/jbc.M111.224089

M3 - Article

C2 - 21680731

AN - SCOPUS:79960982566

VL - 286

SP - 27494

EP - 27505

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -